Quantall is a team forged in 2023 from the shared expertise of seasoned scientists and dedicated professionals passionate about pioneering advancements in biotechnology. With a wealth of experience in the field, our team combines a deep understanding of research methodologies, innovative problem-solving, and a commitment to driving impactful discoveries.
Our mission is to revolutionize drug development through unwavering expertise, collaborative innovation, and a relentless pursuit of scientific excellence. We are committed to empowering breakthroughs, delivering precise solutions, and shaping the future of biotechnology to transform lives globally.
At Quantall, we excel in discovery-based In Vivo and Bioanalytical services, offering comprehensive screening, lead target, and pre-IND enabling studies. Our support extends to high throughput DMPK studies, alongside adept handling of challenging biomarkers—both small and large molecule targets—utilizing cutting-edge LC-MS and Immunoassay (ELISA/MSD) platforms.
Copyright © 2024 Quantall LLC